Randomized Trialhigh evidence

ANGPTL4 Inhibition in Adults with Elevated Triglyceride Levels.

The New England journal of medicine·November 9, 2026·PMID 43002172

Why it matters

Elevated triglycerides and remnant cholesterol are associated with increased cardiovascular risk, yet current therapies often achieve only modest reductions. This trial demonstrates that ANGPTL4 inhibition can produce substantial triglyceride lowering, offering a potential new mechanism for managing atherogenic dyslipidemia in high-risk patients.

Infographic summary of ANGPTL4 Inhibition in Adults with Elevated Triglyceride Levels.
Visual abstract · MedLit

The papers that matter, first.

MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.

§

MedLit · Evidence, Distilled